Teladoc Health, Inc.
TDOC
$7.59
$0.141.88%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -223.59M | -207.36M | -1.01B | -1.00B | -981.73M |
| Total Depreciation and Amortization | 204.88M | 210.96M | 228.46M | 249.81M | 270.60M |
| Total Amortization of Deferred Charges | 164.00M | 157.59M | 144.05M | 133.04M | 121.42M |
| Total Other Non-Cash Items | 139.50M | 144.09M | 965.43M | 948.40M | 963.76M |
| Change in Net Operating Assets | 7.72M | -1.85M | -24.90M | -36.32M | -36.19M |
| Cash from Operations | 292.52M | 303.43M | 300.68M | 293.68M | 337.86M |
| Capital Expenditure | -12.41M | -11.72M | -12.37M | -10.79M | -6.06M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -81.90M | -65.30M | -64.61M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -167.02M | -166.73M | -134.83M | -113.26M | -124.85M |
| Cash from Investing | -261.33M | -243.76M | -211.81M | -124.05M | -130.91M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -550.63M | -550.63M | -- | -- | -- |
| Issuance of Common Stock | 4.04M | 4.48M | 7.61M | 8.49M | 7.54M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.11M | -259.00K | -282.00K | -178.00K | -3.07M |
| Cash from Financing | -550.70M | -546.41M | 7.33M | 8.31M | 4.48M |
| Foreign Exchange rate Adjustments | 1.89M | 3.97M | -804.00K | -3.29M | 1.91M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -517.62M | -482.76M | 95.40M | 174.65M | 213.34M |